Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

.assisTek, the Global Leader Tablet ePROs, Will Be Offering Demonstrations of the TouchPro and iPRO Data Collection Platforms at CBI's 2nd Forum on Patient Reported Outcomes

TouchPRO
TouchPRO

.assisTek, the global leader tablet ePROs, will be offering demonstrations of the assisTek's large 9 inch touch-screens and Apple iPhone ePRO platforms at The Centers for Business Intelligence (CBI) Forum on Patient Reported Outcomes (PRO) conference May 21-22 in Philadelphia, PA.

Scottsdale, AZ (PRWEB) May 8, 2008 -- .assisTek, the global leader tablet ePROs, will be offering demonstrations of assisTek's llarge 9 inch touch-screens and Apple iPhone ePRO platforms at The Centers for Business Intelligence (CBI) Forum on Patient Reported Outcomes (PRO) conference May 21-22 in Philadelphia, PA.

PDA ePRO - iPRO

Jeff Sloan of the Mayo Clinic and other academic and industry thought-leaders will convene at CBI's 2nd Patient Reported Outcomes Conference to share their experiences and knowledge of the FDA Guidance document on patient-reported outcomes.

"We are proud to be a part of this conference. It gives us a chance to meet with PRO professionals face-to-face to hear their challenges. In response to recent developments in the industry, we will demonstrate how TouchPRO and iPRO products deliver data in clinical trials that is over 99% complete, reduce workload by over 90%, and significantly increase both speed to data access and management control," says Joy Hebert, Chief Operating Officer.

Interested conference attendees should contact Gary Coraggio at gary.coraggio@assistek.com to schedule a demonstration.

About .assisTek:
.assisTek is the global leader in Tablet ePROs and has revolutionized the process of collecting patient feedback during clinical trials by helping sites collect the data electronically and systematically through large 9 inch tablet touch-screens, iPhones and on the web.

.assisTek's large touch-screen products are the most advanced in the industry and the .assisTek team has the deepest knowledge and experience in the industry having served more than 45,000 patients in more than 35 therapeutic areas at more than 4,500 sites across 5 continents.

.assisTek, formerly Assist Technologies, can be found on the web at assisTek.com

###

Simillar Articles

.assisTek, the Global Leader Tablet ePROs, Announces the Launch of a New Website at assistek.com
.assisTek, the global leader tablet ePROs, today announced the launch of their new corporate website at http://www.assistek.com . The website features a video interview of site coordinators who...
.assisTek to Offer Demos of the TouchPRO and iPRO Platforms at 17th Annual Partnerships with CROs...
.assisTek, the global leader tablet eDiaries, will be offering demonstrations of the TouchPRO and iPRO platforms at the 17th Annual Partnerships with CROs and Other Outsourcing Providers conference...
.assisTek, the Global Leader Tablet ePROs, Will be Offering Demonstrations of the iPRO and...
.assisTek, the global leader tablet ePROs, will be offering demonstrations of the TouchPRO and iPRO platforms at the International Society for Pharmacoeconomics and Outcomes (ISPOR) conference May...
.assisTek Announces iPRO -- A New Platform for Clinical Trial eDiaries Using the Apple iPhone
.assisTek, the global leader in electronic tablet electronic patient reported outcomes (ePROs), is proud to announce the iPRO, a new platform for clinical trial patient questionnaires (eDiaries)...
Esomeprazole Remains Under Threat
Following the recent revocation by the EPO of a key patent in the array of protection of AstraZeneca's Nexium (Esomeprazole) there remains a degree of uncertainty as to whether it opens the...
Home Terms of Use Privacy Policy Contact Us